Monash Health medical oncologist Dr. Mahendra Naidoo documented a conversation with his colleague, Dr. Dragan Damianovich, a senior gastrointestinal oncologist diagnosed with stage IV pancreatic cancer. This discussion, published in JAMA Oncology, explored the patient experience from a physician's perspective and has resonated widely within the oncology community.
The Physician as Patient
Dr. Damianovich, referred to as "Dr. D," was diagnosed with advanced, inoperable pancreatic cancer following symptoms including new diabetes and unexplained weight loss.
He approached his treatment, full-dose FOLFIRINOX, based on published evidence. However, he noted a crucial distinction:
His body ultimately differed from a clinical trial setting.
Re-evaluating Toxicity and Quality of Life
Dr. D experienced severe oxaliplatin-induced neuropathy. While technically classified as Grade Two toxicity, he described its impact as crippling.
This observation prompted Dr. Naidoo to re-evaluate how toxicity is graded and its individual impact on a patient's quality of life, suggesting current generic grading may underestimate personal consequences.
Perspectives on Evidence and Hope
Despite his symptoms, Dr. D maintained his routines, viewing fatigue as something to be actively resisted. He also discussed the value of complementary, evidence-aligned care, an approach Dr. Naidoo explored with him. Described as a "purist," Dr. D supported integrating wellness support into standard cancer care, recommending allied health professionals for such advice.
Regarding hope, Dr. D acknowledged that his understanding of it changed as a patient.
Despite this, he stated his diagnosis strengthened his belief in hope as the only remaining factor for patients with certain cancers.
His advice to newly diagnosed patients included settling affairs early and trusting their chosen medical team.
Oncology's Challenges: Burnout and Support
Dr. D issued a warning about physician burnout, particularly for younger oncologists. He emphasized the need for early work-life balance and better psychological support.
He noted that oncology, similar to palliative care, involves constant exposure to emotional situations. Dr. D advocated for mandatory clinical supervision in oncology, similar to practices in palliative care, to help clinicians process the emotional demands of their work.
Impact on Dr. Naidoo's Practice
The conversation with Dr. D significantly influenced Dr. Naidoo's professional approach. He reported changes in his communication style, a re-evaluation of toxicity discussions, and a more deliberate approach to discussing the evolving meaning of hope with patients, especially when treatment options are limited.
Dr. Naidoo has also engaged in advanced communication workshops to better structure difficult conversations and prevent patients from feeling abandoned.